OGC
Oak Grove Capital’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-5,000
| Closed | -$397K | – | 59 |
|
|
2022
Q3 | $397K | Buy |
+5,000
| New | +$397K | 0.13% | 45 |
|
|
2019
Q3 | – | Sell |
-29,380
| Closed | -$2.58M | – | 76 |
|
|
2019
Q2 | $2.58M | Buy |
29,380
+3,575
| +14% | +$314K | 1.38% | 21 |
|
|
2019
Q1 | $2.34M | Buy |
25,805
+11,655
| +82% | +$1.06M | 1.47% | 18 |
|
|
2018
Q4 | $1.02M | Buy |
14,150
+1,600
| +13% | +$115K | 0.91% | 24 |
|
|
2018
Q3 | $1.2M | Buy |
12,550
+2,950
| +31% | +$283K | 1.04% | 25 |
|
|
2018
Q2 | $914K | Buy |
9,600
+3,150
| +49% | +$300K | 0.93% | 23 |
|
|
2018
Q1 | $566K | Buy |
+6,450
| New | +$566K | 0.62% | 32 |
|